¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Immunodeficiency associated with major defect, unspecified"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • neural tube defect
    ½Å°æ°ü°á¼Õ, ½Å°æ°ü°áÇÔ
  • ostium primum defect
    ù°±¸¸Û°á¼Õ, Á¦1°ø°á¼Õ
  • outflow tract defect
    À¯Ãâ·Î°á¼Õ
  • plication defect
    ÁÖ¸§Çü¼º°áÇÔ
  • perforation defect
    ¶Õ¸²°áÇÔ, õ°ø°áÇÔ
  • perfusion defect
    °ü·ù°á¼Õ
  • scalp defect
    ¸Ó¸®µ¤°³°á¼Õ, µÎÇǰá¼Õ
  • synthesis defect
    ÇÕ¼º°áÇÔ
  • sector defect
    ºÎä²Ã½Ã¾ß°á¼Õ, ¼±Çü½Ã¾ß°á¼Õ
  • sensory defect
    °¨°¢°á¼Õ
  • separation defect
    ºÐ¸®°áÇÔ
  • septal defect
    »çÀ̸·°á¼Õ, Á߰ݰá¼Õ
  • septation defect
    »çÀ̸·Çü¼º°á¼Õ, Áß°ÝÇü¼º°á¼Õ
  • skull bone defect
    ¸Ó¸®»À°á¼Õ, µÎ°³°ñ°á¼Õ
  • ventricular septal defect
    ½É½Ç»çÀ̸·°á¼Õ, ½É½ÇÁ߰ݰá¼Õ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • outflow tract defect
    À¯Ãâ·Î°á¼Õ
  • perforation defect
    ¶Õ¸²°áÇÔ
  • perfusion defect
    °ü·ù°á¼Õ
  • plication defect
    ÁÖ¸§Çü¼º°áÇÔ
  • quantum defect
    ¾çÀÚ°á¼Õ
  • relative afferent pupillary defect
    ºñ±³µé½Å°æµ¿°ø°á¼Õ
  • retroplastic defect
    ÅðÇຯ¼º°áÇÔ
  • scalp defect
    ¸Ó¸®µ¤°³°á¼Õ, µÎÇǰá¼Õ
  • sector defect
    ºÎä²Ã½Ã¾ß°á¼Õ, ¼±Çü½Ã¾ß°á¼Õ
  • sensory defect
    °¨°¢°á¼Õ
  • separation defect
    ºÐ¸®°áÇÔ
  • septal defect
    »çÀ̸·°á¼Õ, Á߰ݰá¼Õ
  • septation defect
    »çÀ̸·Çü¼º°áÇÔ
  • skull bone defect
    ¸Ó¸®»À°á¼Õ, µÎ°³°ñ°á¼Õ
  • synthesis defect
    ÇÕ¼º°áÇÔ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • amniotic defect
    ¾ç¸·°áÇÔ
  • aortic septal defect
    ´ëµ¿¸ÆÁ߰ݰá¼Õ(ÓÞÔÑØæñḛ́ÌÀáß).
  • aortic septal defect
    ´ëµ¿¸ÆÁ߰ݰá¼Õ(ÓÞÔÑØæñḛ́ÌÀáß).
  • aorticopulmonary septal defect
    ´ëµ¿¸ÆÆóµ¿¸ÆÁ߰ݰá¼Õ(¡­ñḛ́ÌÀáß).
  • aorticopulmonary septal defect
    ´ëµ¿¸ÆÆóµ¿¸ÆÁ߰ݰá¼Õ(¡­ñḛ́ÌÀáß).
  • aortopulmonary septal defect
    ´ëµ¿¸ÆÆóµ¿¸ÆÁ߰ݰá¼Õ.
  • aortopulmonary septal defect
    ´ëµ¿¸ÆÆóµ¿¸ÆÁ߰ݰá¼Õ.
  • functional morphologic defect
    ±â´ÉÇüŰáÇÔ
  • fusion defect
    À¶ÇÕ°áÇÔ
  • fusion defect (cleft palate)
    À¶ÇÕ°áÇÔ (ÀÔõÀå°¥¸²Áõ)
  • gametic defect
    »ý½ÄÀÚ°áÇÔ
  • gene defect
    À¯ÀüÀÚ°á¼Õ<--°á¿©>
  • genetic defect
    À¯ÀüÀû °áÇÔ(¡­ÌÀùè).
  • genetic defect
    À¯ÀüÀÚ°áÇÔ
  • genetic defect
    À¯ÀüÀû °áÇÔ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • scid(severe combined immunodeficiency disease)
    ÁßÁõº¹Çո鿪°áÇ̺´(ñìñøÜÜùêØóæ¹ÌÀù¹Ü»)
  • severe combined immunodeficiency
    ÁßÁõº¹Çո鿪°áÇÌÁõ
  • severe combined immunodeficiency disease
    ÁßÁõº¹Çո鿪°áÇ̺´(ñìñøÜÜùêØóæ¹ÌÀù¹Ü»)
  • simian immunodeficiency virus
  • antigen, major histocompatibility
    ÁÖÁ¶Á÷ÀûÇÕÇ׿ø, MHCÇ׿ø
  • arteria palatina major <³ª>
    ´ë±¸°³µ¿¸Æ, Å«±¸°³µ¿¸Æ{ÇØ}
  • asynergy major
    ´ëÇùµ¿¿îµ¿ºÒ´É(Áõ).
  • canal, major palatine
    ´ë±¸°³°ü, Å«±¸°³°ü{ÇØ}
  • clavicular part of greater pectoral muscle ; pars clavicularis pectoralis major is
    ¼â°ñºÎºÐ ´ëÈä±ÙÀÇ , ¼â°ñºÎ.
  • complex, major histocompatibility
    ÁÖÁ¶Á÷ÀûÇÕº¹ÇÕü
  • curvatura ventriculi major<³ª>
    Å«¸¸°î, ´ë¸¸(ÓÞØ¶).
  • ductus pancreaticus major<³ª>
    ´ëÃé°ü(´ëÃé°ü).
  • ductus pancreaticus major<³ª>
    Å«ÃéÀå°ü, ´ëÃé°ü(ÓÞõýη).
  • ductus sublingualis major <³ª>
    ´ë¼³Çϼ±°ü, Å«Çô¹Ø»ù°ü{ÇØ}
  • ductus sublingualis major<³ª>
    Å«Çô¹Ø»ù°ü, ´ë¼³Çϼ±°ü(ÓÞàßù»àÍη).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • Retroplasia defect
    ÅðÇຯ¼º°áÇÔ
    [¿¾ ¿ë¾î] ÅðÇຯ¼º°áÇÔ
  • Metabolic defect of nucleic acid (Purinemia)
    ÇÙ»ê´ë»ç°áÇÔ(Ç»¸°Ç÷Áõ)
    [¿¾ ¿ë¾î] ÇÙ»ê´ë»ç°áÇÔ(Ç»¸°Ç÷Áõ)
  • Hormone defect (Hermaphroditism)
    È£¸£¸ó°áÇÔ (¹ÝÀ½¾çÁõ)
    [¿¾ ¿ë¾î] È£¸£¸ó°áÇÔ (¹ÝÀ½¾çÁõ)
  • Meoitic defect
    °¨¼öºÐ¿­°áÇÔ
    [¿¾ ¿ë¾î] °¨¼öºÐ¿­±â°áÇÔ
  • Promeiotic defect
    °¨¼öºÐ¿­ÀÌÀü°áÇÔ
    [¿¾ ¿ë¾î] °¨¼öºÐ¿­Àü°áÇÔ
  • Conjunction defect
    °áÇÕ°áÇÔ
    [¿¾ ¿ë¾î] °áÇÕ°áÇÔ
  • Composition defect
    ±¸¼º°áÇÔ
    [¿¾ ¿ë¾î] ±¸¼º°áÇÔ
  • Simple morphologic defect
    ´Ü¼øÇüŰáÇÔ
    [¿¾ ¿ë¾î] ´Ü¼ø¼ºÇüÅÂÇÐÀû°áÇÔ
  • Defect of embryogenesis
    ¹èÀڹ߻ý°áÇÔ
    [¿¾ ¿ë¾î] ¹èÀÚÇü¼º°áÇÔ
  • Multiple morphologic defect
    º¹ÇÕÇüŰáÇÔ
    [¿¾ ¿ë¾î] ´Ù¹ß¼ºÇüÅÂÇÐÀû°áÇÔ
  • Defect of Integument
    ¿ÜÇǰáÇÔ
    [¿¾ ¿ë¾î] ¿ÜÇǰáÇÔ
  • Genetic defect
    À¯ÀüÀÚ°áÇÔ
    [¿¾ ¿ë¾î] À¯ÀüÇÐÀû°áÇÔ
  • Chorionic defect
    À¶¸ð¸·°áÇÔ
    [¿¾ ¿ë¾î] À¶¸ð¸·°áÇÔ
  • Retrogression defect
    ÅðÇà°áÇÔ
    [¿¾ ¿ë¾î] ÅðÈ­¼º°áÇÔ
  • Synthesis defect (Tyrosinosis)
    ÇÕ¼º°áÇÔ (ŸÀ̷νÅÁõ)
    [¿¾ ¿ë¾î] ÇÕ¼º°áÇÔ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
MBP major basic protein; maltose-binding protein; management by policy; mannose-binding protein; mean bl...
MCA major coronary artery; Maternity Center Association; medical care administration; methylcholanthrene...
MD Doctor of Medicine [Lat. Medicinae Doctor]; magnesium deficiency; main duct; maintenance dose; major...
MDC major diagnostic categories; Metoprolol in Dilated Cardiomyography [trial]; minimum detectable conce...
MDD major depressive disorder; mean daily dose
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
FIV Feline Immunodeficiency Virus
AIDS HIV)-acquired immunodeficiency syndrome
HIV-1 Human Immunodeficiency Virus
HIV-1 Human Immunodeficiency Virus 1
HIV Human Immunodeficiency Virus I
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • perceptual defect
    Áö°¢ °á¼Õ
  • peroxidase defect
    °ú»êÈ­È¿¼Ò °á¼Õ
  • punch out defect
    ±¸¸Û °á¼Õ
  • qualitative platelet defect
    Á¤»ó Ç÷¼ÒÆÇ °áÇÌÁõ, ÁúÀû Ç÷¼ÒÆÇ °áÇÔ
  • quantum defect
    ¾çÀÚ °á¼Õ
  • skeletal defect
    °ñ°Ý °á¼Õ
  • small atrial septal defect
    ¹Ì¼¼ ½É¹æ Áß°Ý °á¼Õ
  • substance defect
    ¹°Áú °áÇÌ
  • superficial defect
    Ç¥À缺 °á¼Õ
  • ventricular septal defect
    ½É½Ç Áß°Ý °á¼Õ
    ¼±Ãµ¼º ½ÉÁúȯ¿¡¼­ ºóµµ°¡ ³ôÀº °ÍÀÇ ÇϳªÀÌ´Ù. ½É½Ç Áß°Ý¿¡ °á¼ÕÀÌ ÀÖ´Â °ÍÀ» ¸»ÇÑ´Ù. º¸Åë ½É½Ç Áß°Ý ¸·¼º ºÎÀ§ÀÇ °á¼ÕÀε¥ ±Ù¼º ºÎÀ§¿¡ °á¼ÕÀÌ ÀÖ´Â °Íµµ ÀÖ´Ù. °á¼Õ°øÀÇ Å©±â´Â ´Ù¾çÇÏ´Ù. ÀϹÝÀûÀ¸·Î ¿¹ÈÄ´Â ¾çÈ£Çϰí ÀÚ¿¬ Æó¼âµµ ÀÖ´Ù. Ä¡·á´Â ¿Ü°úÀûÀ¸·Î Æó¼â¸¦ ÇÑ´Ù.
  • visual field defect
    ½Ã¾ß °á¼Õ
    ¸Á¸·¿¡¼­ ´ë³ú ÇÇÁú¿¡ À̸£´Â ½Ã°¢°èÀÇ Àå¾Ö·Î ÀÎÇÑ ½Ã¾ßÀÇ ÀÌ»ó.
  • wedge shape defect
    ¼³»ó °á¼Õ
  • window defect
    â¹® ºñħ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
MBP-associated serine protease <enzyme> Genbank d28593
Registry number: EC 3.4.21.-
Synonym: masp protease, mannose-binding protein-associated serine protease
(26 Jun 1999)
virus-associated haemophagocytic syndrome <syndrome> A syndrome closely resembling malignant histiocytosis but potentially reversible, following a herpes group virus infection such as by the Epstein-Barr virus.
(05 Mar 2000)
Cdc42Hs-associated kinase <enzyme> Specifically binds cdc42hs in its GTP-bound form; 379 aa residues, mw 45 kD; aa sequence given in first source
Registry number: EC 2.7.1.-
(26 Jun 1999)
megakaryocyte-associated tyrosine kinase <enzyme> Genbank l18974
Registry number: EC 2.7.1.-
Synonym: matk protein, csk homologous kinase, chk enzyme
(26 Jun 1999)
Rho-associated kinase <enzyme> Binds the g-protein rho; rock-i and rock-ii are two isoforms; genbank u36909
Registry number: EC 2.7.10.-
Synonym: rho-kinase, rock-i, rock-ii, p160(rock), let-502 kinase
(26 Jun 1999)
growth associated proteins <growth factor> Group of developmentally regulated polypeptides thought to be critical for the formation of neural circuitry. The acidic membrane phosphoprotein GAP 43 is synthesised and transported down regenerating and developing axons, pp46 localised in growth cone membranes during embryogenesis, B 50 in mature presynaptic membranes in the regulation of phosphotidylinositol turnover and F1 in the hippocampus during long-term potentiation, are now all known to be the same protein.
(18 Nov 1997)
RLK5-associated protein phosphatase <enzyme> Associated with serine-threonine receptor-like kinase, rlk5; from arabidopsis thaliana; composed of 3 domains, an amino-terminal signal anchor, a kinase interaction domain and a type 2c protein phosphatase catalytic domain; mw 65 kD; genbank u09505
Registry number: EC 3.1.3.-
Synonym: kapp, kinase-associated protein phosphatase
(26 Jun 1999)
gut-associated lymphoid tissue <physiology> Peripheral lymphoid organ consisting of lymphoid tissue associated with the gut (Peyer's patches, tonsils, mesenteric lymph nodes and the appendix).
It is especially rich in B-cells and is responsible for localised immunity to pathogens such as bacteria, viruses, and parasites.
(20 Sep 2002)
Rous-associated virus A leukaemia virus of the leukosis-sarcoma complex which by phenotypic mixing with a defective (noninfectious) strain of Rous sarcoma virus effects production of infectious sarcoma virus with envelope antigenicity of the RAV.
(05 Mar 2000)
microtubule-associated protein 1B kinase <enzyme> Serine-threonine-specific protein kinase which acts on microtubule-associated protein 1b (map1b); activated by various mitogens; does not act on map2
Registry number: EC 2.7.10.-
Synonym: map1b kinase
(26 Jun 1999)
microtubule-associated protein-2 phosphatase <enzyme> does not fit into any of the classes of protein phosphatases (types 1,2a,2b and 2c) involved in cellular regulation
Registry number: EC 3.1.3.-
Synonym: map-2 phosphatase
(26 Jun 1999)
microtubule-associated proteins <protein> High molecular weight proteins found in the microtubules of the cytoskeletal system. Under certain conditions they are required for tubulin assembly into the microtubules and stabilise the assembled microtubules.
Acronym: MAP
(12 Dec 1998)
myelin-associated glycoprotein A myelin protein found in the periaxonal membrane of both the central and peripheral nervous systems myelin sheaths. It has a structure that is similar to members of the ig superfamily that participate in cell adhesion.
(12 Dec 1998)
croup-associated virus parainfluenza virus type 2
pregnancy-associated alpha-plasma protein An alpha 2-macroglobulin, molecular weight approximately 750,000 now believed to be a pregnancy-specific protein. Its plasma levels increase steadily during the second trimester and continue to rise until the end of gestation.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
ÅëÇÕ°Ë»ö ¿Ï·á